bpc 157 nasal spray vs oral bpc-157 injection vs BPC-157 + TB-500 Nasal Nose-to-Brain Delivery of Therapeutic Peptides

Research-grade 5-amino-1mq dosage protocols typically employ 50100mg daily doses administered subcutaneously, with initial titration starting at 2550mg for tolerance assessment

Research has demonstrated that through its unique mechanism of action involving beta-3 adrenergic receptor modulation and direct interaction with adipose tissue, this peptide offers a scientifically-supported approach to metabolic support and fat oxidation enhancement

You want high local concentration saturating receptors before systemic distribution occurs

This raises an important question about long-term use that does not have a clean answer yet